Table 2 All NADCs and the six most common individual NADCs: percent (N) of visits with viral suppression (HIV RNA viral load ≤400 copies/ml) before cancer onset
Cancer | Within 1 year of onset | Within 2 years of onset | 3-4 years prior to onset | 5-6 years prior to onset | 7-8 years prior to onset | 9-10 years prior to onset |
|---|---|---|---|---|---|---|
All ADCs | 24 % (45) | 18 % (12) | 30 % (45) | 41 % (41) | 43 % (18) | 38 % (11) |
All NADCs | 66 % (577) | 61 % (429) | 61 % (681) | 56 % (468) | 55 % (317) | 65 % (220) |
Infection related | ||||||
Hodgkin | 64 % (30) | 48 % (23) | 20 % (10) | 0 % (0)a | 8 % (1) | 0 % (0)b |
Anal | 65 % (42) | 53 % (28) | 41 % (39) | 20 % (11) | 53 % (10) | 40 % (2) |
Liver | 66 % (42) | 64 % (28) | 64 % (47) | 68 % (49) | 74 % (49) | 65 % (26) |
Infection unrelated | ||||||
Lung | 51 % (80) | 50 % (66) | 60 % (107) | 62 % (78) | 46 % (33) | 44 % (27) |
Prostate | 79 % (118) | 76 % (91) | 71 % (154) | 56 % (106) | 49 % (74) | 66 % (52) |
Mixed | ||||||
Oral | 71 % (52) | 69 % (43) | 74 % (105) | 71 % (61) | 55 % (35) | 50 % (17) |